ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Eculizumab Efficacy in aHUS Pts with Progressing TMA, with or without Prior Renal Transplant

    C. Legendre, L. Greenbaum, N. Sheerin, D. Cohen, A. Gaber, F. Eitner, Y. Delmas, R. Furman, T. Feldkamp, D. Fouque, C. Bedrosian, C. Loirat

    Université Paris Descartes and Hôpital Necker, Paris, France; Emory University, Atlanta, GA; Newcastle University, Newcastle upon Tyne, United Kingdom; Columbia University Medical Center, New York, NY; Methodist Hospital, Houston, TX; University Hospital Aachen, Aachen, Germany; CHU Pellegrin, Bordeaux, France; Weill Cornell Medical College, New York, NY; University Duisburg-Essen, Essen, Germany; Hôpital E. Herriot and Université de Lyon, Lyon, France; Alexion Pharmaceuticals Inc, Cheshire, CT; Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Paris, France

    INTRODUCTION: Ongoing aHUS post renal transplant leads to graft failure within 1 yr in 60% of patients (pts).1 Case reports suggest eculizumab (ecu) prevents ongoing…
  • 2013 American Transplant Congress

    Transplant Dermatology Is an Essential Part of Transplant Care: Report of First Year Experience

    M. Abdelmalek, C. Chung, E. Pritchett, R. Nijhawan, S. Condon, S. Guy, G. Malat, K. Ranganna, A. Doyle

    Dermatology, Drexel University College of Medicine, Philadelphia, PA; Department of Surgery, Drexel University College of Medicine, Philadelphia, PA; Depratment of Medicine, Drexel University College of Medicine, Philadelphia, PA

    Background: It has been well documented that patients who have undergone organ transplantation have a higher incidence of new skin cancers and that this risk…
  • 2013 American Transplant Congress

    Pathogenesis of TIM-4 Mediated Phagocytosis in Mouse Liver Ischemia and Reperfusion Injury (IRI), The

    H. Ji, Y. Zhang, Y. Liu, X. Shen, F. Gao, C. Batikian, R. Busuttil, J. Kupiec-Weglinski

    Dept of Surgery, Dumont-UCLA Liver Transplant Center, Los Angeles, CA

    Background: Macrophages are critical hematopoietic cells in IR-mediated liver inflammation and in the acquisition of hepatic homeostasis. Macrophage TIM-4 expression regulates the engulfment of apoptotic/necrotic…
  • 2013 American Transplant Congress

    Gastric Fundoplication To Prevent Reflux Symptoms in Stomach Transplantation

    R. Mangus, A. Tector, C. Kubal, J. Fridell, R. Vianna

    Transplant Division, Dept of Surgery, Indiana University School of Medicine, Indianapolis, IN

    IntroductionTransplantation of the stomach occurs as part of a multivisceral or modified multivisceral transplant. Severe gastroesophageal reflux (GER) is a common complication associated with stomach…
  • 2013 American Transplant Congress

    Presence of Preformed IgG3 DSA Identifies Patients at Higher Risk of Early Rejection in Liver Transplantation

    H. Kaneku, J. O'Leary, N. Bañuelos, L. Jennings, B. Susskind, G. Klintmalm, P. Terasaki

    UCLA, Los Angeles, CA; Baylor University Medical Center, Dallas, TX; Terasaki Foundation Laboratory, Los Angeles, CA

    Aim: to examine the impact of preformed IgG3 donor-specific HLA antibodies (DSA) in early acute rejection after liver transplantation (LT).Methods: We analyzed 1271 adult LT…
  • 2013 American Transplant Congress

    Incidence, Risk Factors, and Response Rate to Initial Therapy for Clostridum Difficile in Solid Organ Transplant Recipients

    M. Wheeler, J. Deyo, J. Huang, R. Lee, T. Kozlowski, R. Dupuis

    University of North Carolina, Chapel Hill, NC

    Clostridium difficile Infection (CDI) has been shown to occur at a higher rate in the solid organ transplant (SOT) population compared to the general hospitalized…
  • 2013 American Transplant Congress

    First Kidney Graft Survival Is Associated with Second Kidney Transplant Outcomes in Pediatric Patients with Highly Recurrent Disease

    M. Gupta, A. Wood, N. Mitra, S. Furth, P. Abt, M. Levine

    Department of Surgery, Division of Transplantation, University of Pennsylvania, Philadelphia, PA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Intro: Pediatric kidney transplant(KTx) patients with FSGS/SLE/HUS(Focal Segmental Glomerulosclerosis/Lupus/Hemolytic Uremic Syndrome) may experience recurrent disease which negatively impacts graft survival. We examined whether first graft…
  • 2013 American Transplant Congress

    Severity of Cardiac Allograft Vasculopathy after Heart Transplant Is Reduced with Proliferation Signal Inhibitors

    J. Patel, M. Kittleson, M. Rafiei, A. Osborne, D. Chang, L. Czer, J. Kobashigawa

    Cedars-Sinai Heart Institute, Los Angeles, CA

    Background: The multicenter randomized trials of everolimus have demonstrated a significant reduction in 1st Year maximal intimal thickness. It has been demonstrated from a validation…
  • 2013 American Transplant Congress

    Transplant Dermatology Referrals Result in Unexpected Non-Malignant Diagnoses

    M. Abdelmalek, C. Chung, E. Pritchett, R. Nijhawan, G. Malat, S. Guy, A. Doyle

    Drexel University College of Medicine, Philadelphia, PA

    Background:Although the primary focus of transplant dermatology care is the early detection and treatment of skin cancers in an immunocompromised population, a wide variety of…
  • 2013 American Transplant Congress

    Neuropeptide PACAP Mediated Autophagy in Mouse Liver Ischemia and Reperfusion Injury: Modulation Via cAMP/PKA-CREB-KLF4 Pathway

    H. Ji, Y. Zhang, Y. Liu, X. Shen, F. Gao, C. Fong, R. Busuttil, J. Kupiec-Weglinski

    Dept of Surgery, Dumont-UCLA Liver Transplant Center, Los Angeles, CA

    Background: Autophagy (‘self-eating’) represents a critical mechanism for cellular homeostasis and survival response to the stress. We have shown that neuropeptide PACAP (Pituitary Adenylate Cyclase-Activating…
  • « Previous Page
  • 1
  • …
  • 1612
  • 1613
  • 1614
  • 1615
  • 1616
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences